TP53 and neoplasm: Cytoplasmic Bcl-2 expression was positive (Figure 1B) and negative in 131 (70%) and 57 (30%) samples, and nuclear p53 immunoreactivity was categorised in 94 (50%) tumours as positive (Figure 1C) and negative, respectively.